These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6465355)

  • 1. Side effects of scopolamine administration.
    Serby M; Corwin J; Jordan B; Novatt A; Rotrosen J
    Am J Psychiatry; 1984 Aug; 141(8):1010. PubMed ID: 6465355
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversal of postoperative reactions to scopolamine with physostigmine.
    Holzgrafe RE; Vondrell JJ; Mintz SM
    Anesth Analg; 1973; 52(6):921-5. PubMed ID: 4796567
    [No Abstract]   [Full Text] [Related]  

  • 3. Side effects of transdermal scopolamine.
    Wilkinson JA
    J Emerg Med; 1987; 5(5):389-92. PubMed ID: 3668203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of central anticholinergic syndrome in man by physostigmine.
    Duvoisin RC; Katz R
    JAMA; 1968 Nov; 206(9):1963-5. PubMed ID: 5755090
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopaminergic hypersensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia.
    Gerlach J; Reisby N; Randrup A
    Psychopharmacologia; 1974 Jan; 34(1):21-35. PubMed ID: 4593518
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence for a direct cholinergic involvement in the scopolamine-induced amnesia in monkeys: effects of concurrent administration of physostigmine and methylphenidate with scopolamine.
    Bartus RT
    Pharmacol Biochem Behav; 1978 Dec; 9(6):833-6. PubMed ID: 106402
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological evaluation of the cholinergic system in progressive supranuclear palsy.
    Litvan I; Blesa R; Clark K; Nichelli P; Atack JR; Mouradian MM; Grafman J; Chase TN
    Ann Neurol; 1994 Jul; 36(1):55-61. PubMed ID: 8024262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the interaction of drugs with the cholinergic nervous system--V. Characterization of some effects induced by physostigmine in mice: in vivo and in vitro studies.
    Maayani S; Egozi Y; Pinchasi I; Sokolovsky M
    Biochem Pharmacol; 1978 Jan; 27(2):203-11. PubMed ID: 623676
    [No Abstract]   [Full Text] [Related]  

  • 9. Reversal effect of DM-9384 on scopolamine-induced acetylcholine depletion in certain regions of the mouse brain.
    Abe E
    Psychopharmacology (Berl); 1991; 105(3):310-6. PubMed ID: 1798828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic effects of scopolamine eye drops.
    Freund M; Merin S
    Am J Ophthalmol; 1970 Oct; 70(4):637-9. PubMed ID: 5505483
    [No Abstract]   [Full Text] [Related]  

  • 11. Scopolamine and benzodiazepine models of dementia: cross-reversals by Ro 15-1788 and physostigmine.
    Preston GC; Ward C; Lines CR; Poppleton P; Haigh JR; Traub M
    Psychopharmacology (Berl); 1989; 98(4):487-94. PubMed ID: 2570433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo probe of central cholinergic systems.
    Meador KJ; Loring DW; Lee GP; Taylor HS; Hughes DR; Feldman DS
    J Gerontol; 1988 Nov; 43(6):M158-62. PubMed ID: 3183305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose transdermal scopolamine decreases blood pressure in mild essential hypertension.
    Vesalainen RK; Kaila TJ; Kantola IM; Tahvanainen KU; Juhani Airaksinen KE; Kuusela TA; Eckberg DL
    J Hypertens; 1998 Mar; 16(3):321-9. PubMed ID: 9557925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microwave--drug interactions in the cholinergic nervous system of the mouse.
    Monahan JC
    Prog Clin Biol Res; 1988; 257():309-26. PubMed ID: 3344274
    [No Abstract]   [Full Text] [Related]  

  • 15. Modification of the scopolamine effect by sleep deprivation.
    Hort V; Vojtĕchovský M; Brezinová V; Soukupová B; Safratová V
    Act Nerv Super (Praha); 1970 Jan; 12(1):53-4. PubMed ID: 5418659
    [No Abstract]   [Full Text] [Related]  

  • 16. Oxiracetam antagonizes the disruptive effects of scopolamine on memory in the radial maze.
    Magnani M; Pozzi O; Biagetti R; Banfi S; Dorigotti L
    Psychopharmacology (Berl); 1992; 106(2):175-8. PubMed ID: 1549645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing peripheral and central cholinergic system responses.
    Naranjo CA; Fourie J; Herrmann N; Lanctôt KL; Birt C; Yau KK
    J Psychiatry Neurosci; 2000 Sep; 25(4):325-36. PubMed ID: 11022397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive side effects in rats caused by pharmacological agents used to prevent soman-induced lethality.
    Myhrer T; Enger S; Aas P
    Eur J Pharmacol; 2004 Jan; 483(2-3):271-9. PubMed ID: 14729117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of manipulation of cholinergic mechanisms on turning behaviour in mice with unilateral destruction of the nigro-neostriatal dopaminergic system.
    Pycock C; Milson J; Tarsy D; Marsden CD
    Neuropharmacology; 1978 Mar; 17(3):175-83. PubMed ID: 565479
    [No Abstract]   [Full Text] [Related]  

  • 20. The interaction between beta-phenylethylamine and agents which affect the cholinergic nervous system on locomotor activity and toxicity in mice.
    Jackson DM
    Arzneimittelforschung; 1974 Jan; 24(1):24-7. PubMed ID: 4406104
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.